Wang’s study shows that silencing of IDH2 in prostate cancer cells increases glucose consumption and lactate production as well as the production of ROS and leads to the expression of the HIF1a pathway with increased tumor cell invasion but reduces the tumor cell proliferation and tumor volume [87]. Here, IDH2 is linked to neoplasm.